Skip to main content
. 2022 Feb 18;322(4):H568–H574. doi: 10.1152/ajpheart.00019.2022

Table 2.

Serum cytokine and chemokine profile (pg/mL)

  HA MDD P Value
n (men/women) 10 (6/4) 14 (4/10) 0.21
Proinflammatory cytokines
 IL-1β 4.41 (0.78, 10.55) 1.31 (0.69, 5.70) 0.28
 IL-2 1.33 (0.46, 16.09) 0.79 (0.43, 9.91) 0.38
 IL-6 5.93 (0.66, 19.76) 6.46 (0.44, 58.14) 0.47
 IL-8 2.76 (0.72, 9.95) 1.14 (0.66, 7.63) 0.27
 IL-17A 4.40 (0.59, 16.13) 0.68 (0.44, 11.90) 0.22
 TNF-α 7.23 (0.95, 37.77) 1.44 (0.64, 26.08) 0.31
 IFNγ 20.26 (0.45, 64.16) 3.70 (0.42, 76.26) 0.34
 IL-12p70 1.25 (0.77, 3.56) 0.91 (0.52, 9.83) 0.40
 TGF-β1, free active 30.88 (3.57, 99.89) 3.57 (3.57, 34.04) 0.09
Anti-inflammatory cytokines
 IL-4 5.34 (0.68, 120.50) 0.97 (0.68, 60.40) 0.42
 IL-10 5.20 (0.65, 10.99) 1.57 (0.60, 22.19) 0.59
Chemokines
 MCP-1 127.90 (102.70, 222.00) 205.20 (87.15, 256.50) 0.51
 IP-10 128.30 (108.00, 269.00) 139.90 (53.99, 253.20) 0.67

Values (in pg/mL) are medians (25th percentile, 75th percentile); n, number of participants. HA, healthy nondepressed young adults; IFNγ, interferon-γ; IL-1β, interleukin-1β; IP-10 interferon γ-induced protein 10; MCP-1, monocyte chemoattractant protein-1; MDD, major depressive disorder; TNF-α, tumor necrosis factor-α; TGF-β1, transforming growth factor-β1. All data, except sex ratios (fisher’s exact test), were analyzed using Mann–Whitney U test. P > 0.05, no significant difference found in any of the assessed markers.